Analysis of commercial kidney stone probiotic supplements.
Analysis of commercial kidney stone probiotic supplements.
复制标题
DOI:
10.1016/j.urology.2014.11.013
复制
发表时间:
2015-03
期刊:
影响因子:
2.1
通讯作者:
Knight J
中科院分区:
文献类型:
--
作者:
Ellis ML;Shaw KJ;Jackson SB;Daniel SL;Knight J
To examine the levels of Oxalobacter formigenes in probiotic supplements marketed by ™PRO Lab, Ltd, Toronto, Canada, and capsules of Oxalo™ purchased from Sanzyme Ltd, Hyderabad, India, and to measure the ability of these preparations to degrade oxalate in vitro. Probiotic supplements and pure cultures of O. formigenes were cultured in a number of media containing oxalate. OD595 was used to measure bacterial growth and ion chromatography was used to measure loss of oxalate in culture media. O. formigenes specific and degenerate Lactobacillus primers to the oxalate decarboxylase gene (oxc) were used in PCR. Incubating probiotic supplements in different media did not result in growth of oxalate-degrading organisms. PCR indicated the absence of organisms harboring the oxc gene. Culture and 16S rRNA gene sequencing indicated the ™PRO Lab supplement contained viable Lactococcus lactis subsp. lactis (GenBank accession no. KJ095656.1), while Oxalo™ contained several Bacillus species and Lactobacillus plantarum. The probiotic supplement sold over the internet by ™PRO Lab, Ltd and Sanzyme Ltd did not contain identifiable O. formigenes or viable oxalate-degrading organisms, and they are unlikely to be of benefit to calcium oxalate kidney stone patients.
登录
查看更多内容
影响因子:
3.2
作者:
Costa, T;Steil, L;Henriques, AO
通讯作者:
Henriques, AO
影响因子:
13.6
作者:
Kaufman, David W.;Kelly, Judith P.;Cave, David R.
通讯作者:
Cave, David R.
影响因子:
168.9
作者:
Sidhu, H;Hoppe, B;Peck, AB
通讯作者:
Peck, AB
影响因子:
2.8
作者:
ALLISON, MJ;DAWSON, KA;FOSS, JG
通讯作者:
FOSS, JG
影响因子:
6.1
作者:
Hoppe, Bernd;Groothoff, Jaap W.;Milliner, Dawn
通讯作者:
Milliner, Dawn